# Teradyne, Inc: financial statements, quarterly

TER · Nasdaq · CIK 97210 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ter.md) · [Financials](/companies/ter/financials.md) · [Filings](/companies/ter/filings.md) · [Insiders](/companies/ter/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ter/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [704](/filings/0000950170-24-119923.md) | [671 d](/filings/0001193125-26-059002.md) | [600](/filings/0000950170-25-062503.md) | [730](/filings/0000950170-25-101248.md) | [737](/filings/0001193125-25-258477.md) | [753 d](/filings/0001193125-26-059002.md) | [686](/filings/0001193125-26-201058.md) | [652](/filings/0001193125-26-327715.md) | [769](/filings/0001193125-25-258477.md) | [1,083 d](/filings/0001193125-26-059002.md) | [1,282](/filings/0001193125-26-201058.md) | [1,329](/filings/0001193125-26-327715.md) |
| Cost of revenue | $m | [305](/filings/0000950170-24-119923.md) | [291 d](/filings/0001193125-26-059002.md) | [261](/filings/0000950170-25-062503.md) | [304](/filings/0000950170-25-101248.md) | [301](/filings/0001193125-25-258477.md) | [306 d](/filings/0001193125-26-059002.md) | [270](/filings/0001193125-26-201058.md) | [279](/filings/0001193125-26-327715.md) | [320](/filings/0001193125-25-258477.md) | [464 d](/filings/0001193125-26-059002.md) | [502](/filings/0001193125-26-201058.md) | [534](/filings/0001193125-26-327715.md) |
| Gross profit | $m | [398](/filings/0000950170-24-119923.md) | [380 d](/filings/0001193125-26-059002.md) | [339](/filings/0000950170-25-062503.md) | [426](/filings/0000950170-25-101248.md) | [437](/filings/0001193125-25-258477.md) | [447 d](/filings/0001193125-26-059002.md) | [415](/filings/0001193125-26-201058.md) | [373](/filings/0001193125-26-327715.md) | [449](/filings/0001193125-25-258477.md) | [620 d](/filings/0001193125-26-059002.md) | [781](/filings/0001193125-26-201058.md) | [795](/filings/0001193125-26-327715.md) |
| Selling, general and administrative | $m | [138](/filings/0000950170-24-119923.md) | [142 d](/filings/0001193125-26-059002.md) | [149](/filings/0000950170-25-062503.md) | [154](/filings/0000950170-25-101248.md) | [158](/filings/0001193125-25-258477.md) | [156 d](/filings/0001193125-26-059002.md) | [157](/filings/0001193125-26-201058.md) | [158](/filings/0001193125-26-327715.md) | [169](/filings/0001193125-25-258477.md) | [165 d](/filings/0001193125-26-059002.md) | [167](/filings/0001193125-26-201058.md) | [193](/filings/0001193125-26-327715.md) |
| Operating income | $m | [144](/filings/0000950170-24-119923.md) | [124 d](/filings/0001193125-26-059002.md) | [77.8](/filings/0000950170-25-062503.md) | [210](/filings/0000950170-25-101248.md) | [152](/filings/0001193125-25-258477.md) | [154 d](/filings/0001193125-26-059002.md) | [121](/filings/0001193125-26-201058.md) | [90.7](/filings/0001193125-26-327715.md) | [145](/filings/0001193125-25-258477.md) | [293 d](/filings/0001193125-26-059002.md) | [473](/filings/0001193125-26-201058.md) | [438](/filings/0001193125-26-327715.md) |
| Interest expense | $m | [1.0](/filings/0000950170-24-119923.md) | [0.8 d](/filings/0001193125-26-059002.md) | [0.7](/filings/0000950170-25-062503.md) | [1.5](/filings/0000950170-25-101248.md) | [0.8](/filings/0001193125-25-258477.md) | [0.6 d](/filings/0001193125-26-059002.md) | [0.8](/filings/0001193125-26-201058.md) | [0.8](/filings/0001193125-26-327715.md) | [1.3](/filings/0001193125-25-258477.md) | [3.9 d](/filings/0001193125-26-059002.md) | [3.2](/filings/0001193125-26-201058.md) | [3.0](/filings/0001193125-26-327715.md) |
| Income tax | $m | [16.2](/filings/0000950170-24-119923.md) | [22.8 d](/filings/0001193125-26-059002.md) | [8.7](/filings/0000950170-25-062503.md) | [33.1](/filings/0000950170-25-101248.md) | [12.3](/filings/0001193125-25-258477.md) | [5.4 d](/filings/0001193125-26-059002.md) | [14.5](/filings/0001193125-26-201058.md) | [12.3](/filings/0001193125-26-327715.md) | [23.3](/filings/0001193125-25-258477.md) | [29.2 d](/filings/0001193125-26-059002.md) | [62.2](/filings/0001193125-26-201058.md) | [66.8](/filings/0001193125-26-327715.md) |
| Net income | $m | [128](/filings/0000950170-24-119923.md) | [117 d](/filings/0001193125-26-059002.md) | [64.2](/filings/0000950170-25-062503.md) | [186](/filings/0000950170-25-101248.md) | [146](/filings/0001193125-25-258477.md) | [146 d](/filings/0001193125-26-059002.md) | [98.9](/filings/0001193125-26-201058.md) | [78.4](/filings/0001193125-26-327715.md) | [120](/filings/0001193125-25-258477.md) | [257 d](/filings/0001193125-26-059002.md) | [399](/filings/0001193125-26-201058.md) | [375](/filings/0001193125-26-327715.md) |
| Diluted EPS | $ per share | [0.78](/filings/0000950170-24-119923.md) | not reported | [0.40](/filings/0000950170-25-062503.md) | [1.14](/filings/0000950170-25-101248.md) | [0.89](/filings/0001193125-25-258477.md) | not reported | [0.61](/filings/0001193125-26-201058.md) | [0.49](/filings/0001193125-26-327715.md) | [0.75](/filings/0001193125-25-258477.md) | not reported | [2.53](/filings/0001193125-26-201058.md) | [2.38](/filings/0001193125-26-327715.md) |
| Basic EPS | $ per share | [0.83](/filings/0000950170-24-119923.md) | not reported | [0.42](/filings/0000950170-25-062503.md) | [1.18](/filings/0000950170-25-101248.md) | [0.89](/filings/0001193125-25-258477.md) | not reported | [0.61](/filings/0001193125-26-201058.md) | [0.49](/filings/0001193125-26-327715.md) | [0.75](/filings/0001193125-25-258477.md) | not reported | [2.55](/filings/0001193125-26-201058.md) | [2.39](/filings/0001193125-26-327715.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [637](/filings/0000950170-23-058679.md) | [758](/filings/0000950170-25-023784.md) | [707](/filings/0000950170-24-052761.md) | [422](/filings/0000950170-24-089858.md) | [510](/filings/0000950170-24-119923.md) | [553](/filings/0001193125-26-059002.md) | [476](/filings/0000950170-25-062503.md) | [339](/filings/0000950170-25-101248.md) | [273](/filings/0001193125-25-258477.md) | [294](/filings/0001193125-26-327715.md) | [242](/filings/0001193125-26-201058.md) | [350](/filings/0001193125-26-327715.md) |
| Current assets | $m | [2,099](/filings/0000950170-23-058679.md) | [2,162](/filings/0000950170-25-023784.md) | [2,065](/filings/0000950170-24-052761.md) | [1,756](/filings/0000950170-24-089858.md) | [1,839](/filings/0000950170-24-119923.md) | [1,816](/filings/0001193125-26-059002.md) | [1,756](/filings/0000950170-25-062503.md) | [1,584](/filings/0000950170-25-101248.md) | [1,750](/filings/0001193125-25-258477.md) | [1,949](/filings/0001193125-26-327715.md) | [2,173](/filings/0001193125-26-201058.md) | [2,366](/filings/0001193125-26-327715.md) |
| Total assets | $m | [3,371](/filings/0000950170-24-119923.md) | [3,487](/filings/0001193125-26-059002.md) | [3,411](/filings/0000950170-25-062503.md) | [3,632](/filings/0000950170-25-101248.md) | [3,770](/filings/0001193125-25-258477.md) | [3,709](/filings/0001193125-26-059002.md) | [3,706](/filings/0001193125-26-201058.md) | [3,762](/filings/0001193125-26-327715.md) | [3,964](/filings/0001193125-25-258477.md) | [4,184](/filings/0001193125-26-327715.md) | [4,434](/filings/0001193125-26-201058.md) | [4,926](/filings/0001193125-26-327715.md) |
| Current liabilities | $m | [641](/filings/0000950170-23-058679.md) | [660](/filings/0000950170-25-023784.md) | [554](/filings/0000950170-24-052761.md) | [626](/filings/0000950170-24-089858.md) | [595](/filings/0000950170-24-119923.md) | [625](/filings/0001193125-26-059002.md) | [649](/filings/0000950170-25-062503.md) | [675](/filings/0000950170-25-101248.md) | [995](/filings/0001193125-25-258477.md) | [1,115](/filings/0001193125-26-327715.md) | [1,012](/filings/0001193125-26-201058.md) | [1,114](/filings/0001193125-26-327715.md) |
| Total liabilities | $m | [929](/filings/0000950170-23-058679.md) | [961](/filings/0000950170-25-023784.md) | [853](/filings/0000950170-24-052761.md) | [901](/filings/0000950170-24-089858.md) | [867](/filings/0000950170-24-119923.md) | [889](/filings/0001193125-26-059002.md) | [908](/filings/0000950170-25-062503.md) | [925](/filings/0000950170-25-101248.md) | [1,246](/filings/0001193125-25-258477.md) | [1,388](/filings/0001193125-26-327715.md) | [1,290](/filings/0001193125-26-201058.md) | [1,452](/filings/0001193125-26-327715.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [200](/filings/0001193125-25-258477.md) | [200](/filings/0001193125-26-327715.md) | [0.0](/filings/0001193125-26-201058.md) | [0.0](/filings/0001193125-26-327715.md) |
| Shareholders' equity | $m | [2,441](/filings/0000950170-24-119923.md) | [2,526](/filings/0001193125-26-059002.md) | [2,558](/filings/0000950170-25-101248.md) | [2,731](/filings/0001193125-25-258477.md) | [2,903](/filings/0001193125-25-258477.md) | [2,819](/filings/0001193125-26-201058.md) | [2,797](/filings/0001193125-26-201058.md) | [2,837](/filings/0001193125-25-258477.md) | [2,717](/filings/0001193125-25-258477.md) | [2,796](/filings/0001193125-26-327715.md) | [3,144](/filings/0001193125-26-201058.md) | [3,437](/filings/0001193125-26-327715.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [174 d](/filings/0000950170-24-119923.md) | [249 d](/filings/0001193125-26-059002.md) | [7.3](/filings/0000950170-25-062503.md) | [216 d](/filings/0000950170-25-101248.md) | [166 d](/filings/0001193125-25-258477.md) | [283 d](/filings/0001193125-26-059002.md) | [162](/filings/0001193125-26-201058.md) | [182 d](/filings/0001193125-26-327715.md) | [49.1 d](/filings/0001193125-25-258477.md) | [282 d](/filings/0001193125-26-059002.md) | [265](/filings/0001193125-26-201058.md) | [469 d](/filings/0001193125-26-327715.md) |
| Capital expenditure | $m | [34.6 d](/filings/0000950170-24-119923.md) | [44.3 d](/filings/0001193125-26-059002.md) | [44.0](/filings/0000950170-25-062503.md) | [44.8 d](/filings/0000950170-25-101248.md) | [51.8 d](/filings/0001193125-25-258477.md) | [57.4 d](/filings/0001193125-26-059002.md) | [64.0](/filings/0001193125-26-201058.md) | [50.4 d](/filings/0001193125-26-327715.md) | [46.7 d](/filings/0001193125-25-258477.md) | [62.9 d](/filings/0001193125-26-059002.md) | [64.7](/filings/0001193125-26-201058.md) | [90.7 d](/filings/0001193125-26-327715.md) |
| Dividends paid | $m | [16.9](/filings/0000950170-23-058679.md) | [16.8 d](/filings/0001193125-26-059002.md) | [18.4](/filings/0000950170-25-062503.md) | [19.0](/filings/0000950170-25-101248.md) | [19.6 d](/filings/0001193125-25-258477.md) | [19.5 d](/filings/0001193125-26-059002.md) | [19.4](/filings/0001193125-26-201058.md) | [19.2](/filings/0000950170-25-101248.md) | [19.0 d](/filings/0001193125-25-258477.md) | [18.7 d](/filings/0001193125-26-059002.md) | [20.4](/filings/0001193125-26-201058.md) | [20.3 d](/filings/0001193125-26-327715.md) |
| Share repurchases | $m | [119 d](/filings/0000950170-24-119923.md) | [50.7 d](/filings/0001193125-26-059002.md) | [22.1](/filings/0000950170-25-062503.md) | [8.2 d](/filings/0000950170-25-101248.md) | [24.7 d](/filings/0001193125-25-258477.md) | [144 d](/filings/0001193125-26-059002.md) | [157](/filings/0001193125-26-201058.md) | [117 d](/filings/0001193125-26-327715.md) | [244 d](/filings/0001193125-25-258477.md) | [183 d](/filings/0001193125-26-059002.md) | [5.5](/filings/0001193125-26-201058.md) | [68.7 d](/filings/0001193125-26-327715.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.2](/filings/0000950170-23-058679.md) | [166](/filings/0000950170-24-052761.md) | [165](/filings/0000950170-24-089858.md) | [164](/filings/0000950170-24-119923.md) | [162](/filings/0000950170-25-062503.md) | [163](/filings/0000950170-25-101248.md) | [164](/filings/0001193125-25-258477.md) | [162](/filings/0001193125-26-201058.md) | [160](/filings/0001193125-26-327715.md) | [159](/filings/0001193125-25-258477.md) | [158](/filings/0001193125-26-201058.md) | [158](/filings/0001193125-26-327715.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 156,340,750 at 2026-07-27, from the cover of the [10-Q filed 2026-07-31](/filings/0001193125-26-327715.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.